CAAS Capital Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
ACM
CAAS Capital Management's BSX.PRA Position: Q3 2020 in Review
CAAS Capital Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q3 2020, closing a stake of 10,000 shares — an estimated $1.05M sold.
CAAS Capital Management first reported a position in BSX.PRA in Q2 2020 and held it in 1 quarter. The position peaked at $1.05M in Q2 2020. 43 funds tracked by Wall St. Rank hold BSX.PRA as of Q3 2020.
- CAAS Capital Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q3 2020 after selling out during the quarter.
- CAAS Capital Management sold 10,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q3 2020, an estimated $1.05M.
- CAAS Capital Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 1 quarter.
- CAAS Capital Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $1.05M in Q2 2020.
- 43 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q3 2020.
Based on CAAS Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.